C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) C07K 14/00 (2006.01) C07K 14/705 (2006.01) C07K 14/72 (2006.01) C12N 5/16 (2006.01) C12N 15/16 (2006.01) C12N 15/63 (2006.01) G01N 33/53 (2006.01) G01N 33/566 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2326694
A new galanin receptor, GALR3, is described. Also provided are nucleic acids encoding same and various assays to identify ligands particular to said receptor. Ligands so identified are useful for the treatment of obesity, treatment of pain, and treatment of cognitive disorders.
L'invention concerne un nouveau récepteur, GAKR3, de la galanine. Elle concerne également des acides nucléiques codant pour ce récepteur et divers dosages permettant d'identifier des ligands propres audit récepteur. Les ligands ainsi identifiés conviennent bien pour le traitement de l'obésité, de la douleur et des troubles cognitifs.
Cascieri Margaret
Howard Andrew
Lynch Kevin
Smith Roy
Sullivan Kathleen
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
University Of Virginia Patent Foundation
LandOfFree
Galanin receptor galr3 and nucleotides encoding same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Galanin receptor galr3 and nucleotides encoding same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galanin receptor galr3 and nucleotides encoding same will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1529485